ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000834.1|Novobiocin_2 # 55 # 654 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.628	BGC0000834.1|Novobiocin_2 	55	654	+	Loose	550	24.2534	LRA-17	34.88	3002512	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	GTGAGGCCGACGGCAGGGGACGCGACCCCCGTTGACAGCGGACAACCGAGCGACACCACGTATGGCGGCCTGGAAGTCTCGGCCGAGAGGACCAGACTTCGGATCCCGCGGGACCTCTCCTTGGAGGCCTGGTGCCGTCTCGGCGGAAGGATCCTCGCGGTGTGCGATTCATCGGTGTGGTGGATCGGCGACTGGCTGGTGTTCGGACAGAACCAATACGGTGACCGATACCGCCGGGCGATGAAAGAGACCAAGCTCGACTACCAGACACTGCGCAATTACGCCTGGGTGGCGAGAAAATTCGAGCCGTCTCGCCGGCGAGACAGCCTCACGTTCCAACATCACATGGAAGTGGCGGCTCTCTCGGAAGCCGAACAGGACCACTGGCTCGATTTCGCGGTCCGACTGAATTGGTCGAGGAACGAGCTGCGCAAACAGATCCGGGCCAGCTTGTCGGGCGAAGAAGACGACCTCCGGTGCGAGGTCCAACTCAACCTCCAGTTGGACGAGTTACGTCTCGAACGGTGGAGGGAGGCGGCGCGGGGGAGCAATCTGACTCTGACGGACTGGATCCTGTCCGTCGTGGACGGGGCCGTTTGA	MRPTAGDATPVDSGQPSDTTYGGLEVSAERTRLRIPRDLSLEAWCRLGGRILAVCDSSVWWIGDWLVFGQNQYGDRYRRAMKETKLDYQTLRNYAWVARKFEPSRRRDSLTFQHHMEVAALSEAEQDHWLDFAVRLNWSRNELRKQIRASLSGEEDDLRCEVQLNLQLDELRLERWREAARGSNLTLTDWILSVVDGAV	MSIFRTILFVSILLLTSLANSPHATAQVTNTDRPEWSKPYKPFRIAGNIYYVGTYDLACYLITTPQGHILINAALAGTVDQVKANVEALGFKFSDIKILLISQAHFDHVGGLAAIQKMTGAKVMIDDQDAPVVEDGGNSDYIYGGKGVGSLFAPVHVDRKLHDHDNITLGGTQLEMLHHPGHTKGSCSYLLTVKDEHRSYRVLIANIPYMLSEVTLPGMPTYPNVGKDFMYTYGAMRKLQFDIWVAAHSSQFGLQDVRKETDGYNPGAFGDKKKYLTTIDKTEDIYKEHFKGGK	67.69	gnl|BL_ORD_ID|813|hsp_num:0	883			384	513	
BGC0000834.1|Novobiocin_3 # 760 # 1818 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=6bp;gc_cont=0.705	BGC0000834.1|Novobiocin_3 	760	1818	+	Loose	500	30.0314	blaC	36.14	3007182	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam; penem	antibiotic inactivation	class A Mycobacterium tuberculosis bla beta-lactamase	ATGATCGGCACATCCATCGGTCTGGCGCTGCGGAAGCAAGGCGTCGACTCCTACCTCATGGACACCAGTCCCGTCGCACTGCGCATCGCCGAAGCAGTCGGCGCCGGGACGGCCGAGGAACCGCCGGAAACGGTGGACCTGGCGGTGGTCGCCGTACCACCGGTCCACGTGGCACCGGTGATCGCCTCCCACCAGTCGAGGGGAACCGCCCGCTTCTACGTCGACGTGGCCGGTGTGAAGGTCTCCACCCGGCGTGAACTGGACGCACTGGGCTGTGACCTTGCCACGGTGGTGGGCGGTCATCCGCTGGTGGGACGGCCGGGGTCGGGCCCCCTGGCGGCGCGGGGCGACCTGTTCGACGGACGGCCGTGGGCGCTCGTCCCCGCGGTGGGAACAGACGCCGCCGCACTGAACCGCGCTCTCGAACTGGTCGCCGCCTGCGGCGCGATACCGGTCGTCCTGGACGCCGAGGCGCACGACAGGGCGATCGCTCTCGGCACACTCGTCCCCCAGATCGCCCTCACTCTCGTCGCCGCTCGCCTCACGGAGGCGGACAGTGGCGCGTTACGGTTGCTGGGCAGCGTGTGGTCGGAGATACCTCAGCTCGTCGGGGTCGACTCCGCCACCTCGTGGACACAGGTCCTCGCCGCGAACGCGGCTCCGGTCGTGGGTGAACTGGAGAAGCTGAGCCGGGACTTGGCGAGCCTGTTGGAGACGCTCAGAGGTGTCGCCGACGGGGACGGCTCGCTCGCGGAGCCCGACGGGCGACTGCTGGAGTTCATCCAGCGTGGCATCGACGGCTCCAACCGCGTTCCCGGAAGGTACGGGATCCCCACGGAGACCGCGCTCGCGGACGTCGACGTGTCCGTGGACGACCGGCCGGCCGAGCTGGCCCGCCTCTTCGACGACGTGGCCGGCGCCGGGGTGGTGATGCGCGGCATCGACATCTCGCAGCGGCCCGACAGCCCCGACCGTACGGTCACCATTTCGGTCACCCCGCGCGACGCCGAGAACCTCCTGCACGAACTGCGCCGCAGGAAGTGGCCGGCGAACTCCTGA	MIGTSIGLALRKQGVDSYLMDTSPVALRIAEAVGAGTAEEPPETVDLAVVAVPPVHVAPVIASHQSRGTARFYVDVAGVKVSTRRELDALGCDLATVVGGHPLVGRPGSGPLAARGDLFDGRPWALVPAVGTDAAALNRALELVAACGAIPVVLDAEAHDRAIALGTLVPQIALTLVAARLTEADSGALRLLGSVWSEIPQLVGVDSATSWTQVLAANAAPVVGELEKLSRDLASLLETLRGVADGDGSLAEPDGRLLEFIQRGIDGSNRVPGRYGIPTETALADVDVSVDDRPAELARLFDDVAGAGVVMRGIDISQRPDSPDRTVTISVTPRDAENLLHELRRRKWPANS	MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLGVYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPVAQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDAEEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAGFPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAATCVAGVLA	114.66	gnl|BL_ORD_ID|4814|hsp_num:0	5800			21	270	cefoxitin; amoxicillin; cefalotin; temocillin; ticarcillin
BGC0000834.1|Novobiocin_4 # 2131 # 2880 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGGT;rbs_spacer=10bp;gc_cont=0.724	BGC0000834.1|Novobiocin_4 	2131	2880	+	Loose	450	28.1054	SSA	50.0	3007442	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	SSA beta-lactamase	ATGCACCGGCTGTGGGCGGCTCGTTTCCGAGGCGACGAATCGATCGAGGTCGTATTCGTCGACGGCTCCCCGGCCGATGTGTTCGTTCTCGCGGTCGAGTTGAACCGTGCGCACGGCCTGCCGCTCACGCTGGACGAGCGCAAATCCGCCGCCGCCCAGATCATGGATTCACACCCGCACTGGTCCGACCGCAAGATCGCACGGACCACCGGACTGGCGGCCAGCACCGTCGCGTCGCTGAGGTCGTCGTCCACCGCCGGCACGGTCGGGCGCAGGACCGGCCAGGACGGCCGGAGCCGGCCCAACGACGGTACGGACGGACGGCAGCGCGCCGCCGCCCTGCTGGCCCGGAATCCGAACGCGTCGCTTCGCGAGGTGACCAGAGCCGCGGGGATCTCGGTCGGCACCGCCAGCGATGTGCGCGCCAGACTGCGGCGGGGGGAGCCGGCGCTCACCGCCCGGCAGCAGGCCGTGATGAAACTGCGCCCCGCCGCGGCTCAGCGGAGCGGCCCGGACTACGGCCGCGTACTGGAAAACCTGCGCAAGGACCCGTCGCTGCGCTTCACCGACCTCGGCCGGCGCCTGCTCCGCCTGCTCGACGGCTCCGTCCCCGGCAGTGTCGAGCAGATCGCCCAGATCGCGGACGGCGTGCCGGAACACTGCCGGACCGTGGTGGTCGACATGGCCCGCGAGTGCGCCGCCGCCTGGCAGCATCTCGCCGACCAGCTCGCCGACCGGGACACCGCCTGA	MHRLWAARFRGDESIEVVFVDGSPADVFVLAVELNRAHGLPLTLDERKSAAAQIMDSHPHWSDRKIARTTGLAASTVASLRSSSTAGTVGRRTGQDGRSRPNDGTDGRQRAAALLARNPNASLREVTRAAGISVGTASDVRARLRRGEPALTARQQAVMKLRPAAAQRSGPDYGRVLENLRKDPSLRFTDLGRRLLRLLDGSVPGSVEQIAQIADGVPEHCRTVVVDMARECAAAWQHLADQLADRDTA	MKRIFPAYILLTAFLLACSSNATTQNANQSNKPAAAQEAKADDKQNRELQKQIEQIASAARGRVGVHAVVLETGESVSLDEQGRFPMQSVYKFPIGMAVLAQVDAGKLKLDERVRVEKSEYVREGMHSPLRDKNPNEAEVSVRELLRLAVSESDGTASDVLFRLAGGSEAITRYLSDLKVTEIIVADTEKEIGQDWDTQYRNWASPKGAVMLLRAFHEGRGLSAESRALLLKLMTDTPTGPKRLKGLLPKGTVVAHKTGTSGANASGISAATNDIGIVTLPNGRHLAIAVFVSDSPADLTTREGVIAKVAKAAWDQWGK	78.06	gnl|BL_ORD_ID|4942|hsp_num:0	5934			396	516	cefoxitin; ceftazidime; amoxicillin; ampicillin
BGC0000834.1|Novobiocin_5 # 3076 # 4878 # 1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=AGGGG;rbs_spacer=5bp;gc_cont=0.694	BGC0000834.1|Novobiocin_5 	3076	4878	+	Loose	1000	136.346	almE	26.09	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	TTGTTCAACACACGTGCGAACAAAGCTTCTGATCAGTCGCCGACAATACCGACGGAATCGGCCACCCTGGCCGAACTCTGGGAGCGGACGGTACGAAGTCGGCCGAGCAGCCCGGCAATTGTCACCAACGGCGAGACCCTGTCCTACGACGAGGTCAACGCCAGGGCGAACCGGCTGGCACGACTGCTGCTCGACGAGGGGGCGGGCCCGGGCCGTCTGGTGGCACTGGCGCTGCCCCGCTCCAGTCATCTGGTGATCAGCGTGCTTGCCGTGGCCAAGGCCGGCGCGGTGTTCCTGCCGCTGGACGTCAACCACCCGCGGGAGCGGCTCTCGTACCAACTCGCCGATGCCCGGCCCGCGTTGCTGTGCACCGTCCGAAGCGCCGCCGCGAGACTGCCGGACGGCATCGAGATGCCGCGGGTGCTGCTGGACTCGCCCGAGCGCACCGCCGTACTCGACGCACTGCCCGACACCGACCTGACCGACGACGAACGCGGCGGACCGCTCGCCGCGACGGACCTGGCCTACGTGATCTACACCTCCGGCTCGACAGGCCGGCCGAAAGGCGTCGCGCTGACCGGCGCCGGGTTGCCGGCCCTGGCAGCGGCCAAGGTCGCCGCGATGCGGGTCACCGGGGACAGCCGGGTGCTCCAGTTCGCGTCGCCGGGCTTCGACGCCTACCTGACCGAACTGCTGGCCGCGTTCACCGCCGGTGCCACTCTCGTGGTGCCGGGAACGGACACGCTCGCCGGTGACCCGCTGCGAAGGGCCTTGCGGGACGGCCGGGTGAGCCACGCTGTGCTGCCGCCCGCGGCGGTCGCGACCATGTCCCCGGACGCGGTGCCCGACCTGCGCGTGCTGGTGGTGGCGGGCGAGGCGTGCCCGGCCGGCCTGGTCGAACGGTGGGCGCCCGGCCGCCTTCTGATCAACGCCTACGGTCCGACCGAGTGCACGGTGTGCGCGACCATGACCGGCCCGCTCACCCCGACGGACGAGGTCACCATCGGCCGGCCGATTCCCGGCGTGTCCGTGTACATCCTCGACGCCGAACGACGCCCGGCCGCGCCCGGAGAGATCGGCGAGTTGTACCTCAGCGGTGCCGGGCTGGCCCAGGGCTACCTCAACAGCCCCGACCTGACGGCCCAGATGTTCGTACCCAACCCGTTCGCCGCCGACGGCGAACGGATGTACCGCACGGGCGATCTGGCCTCCAGGCGGGCCGACGGCGACATCCTCTTCCACGGCCGGATCGATGATCAGGTCGAACTGCGCGGATTCCGCGTCGAGTTGGGAGAGGTGGAGTCCGTACTCAGCCAACATCCGGACGTGGCACAGGCGGTGGCCGCGCTGTGGACCGATCCGGCCGAGGGGCCGCAGTTGGTGACGTACGTCGTCCCGGCACCCGGCACCACGCCGTCGGCGGGCGAACTGCGTGAGCACGCCGGCCGCTTCCTGCCCGACTTCATGGTGCCGTCGGCATTCACGACCATCGACGCCGTTCCCCTGACTCCCGGCGGAAAGACGGACCGGGCCGGGCTGCCGGATCCGGTGAAAGCCACCCAGCCTGCCGGACTTGGCCCGCGTACTCCTGCCGAGAAGGTCCTCTGTGACATATTCCGGGACCTGTTCGACCTTGTTGAGATCGACGTGCGCAGTAATTTCTTCGAAATGGGCGGGAACAGCATTCTGGCTGTCGACCTCATTCAGCGAGCGCAAGAAGCCGGCTTGACGCTCATGCCGAGGACCGTGATCGACCACCCCACCATCGAGCAACTGGCCGCGATAGCGACCCTCGAGGAGTGA	MFNTRANKASDQSPTIPTESATLAELWERTVRSRPSSPAIVTNGETLSYDEVNARANRLARLLLDEGAGPGRLVALALPRSSHLVISVLAVAKAGAVFLPLDVNHPRERLSYQLADARPALLCTVRSAAARLPDGIEMPRVLLDSPERTAVLDALPDTDLTDDERGGPLAATDLAYVIYTSGSTGRPKGVALTGAGLPALAAAKVAAMRVTGDSRVLQFASPGFDAYLTELLAAFTAGATLVVPGTDTLAGDPLRRALRDGRVSHAVLPPAAVATMSPDAVPDLRVLVVAGEACPAGLVERWAPGRLLINAYGPTECTVCATMTGPLTPTDEVTIGRPIPGVSVYILDAERRPAAPGEIGELYLSGAGLAQGYLNSPDLTAQMFVPNPFAADGERMYRTGDLASRRADGDILFHGRIDDQVELRGFRVELGEVESVLSQHPDVAQAVAALWTDPAEGPQLVTYVVPAPGTTPSAGELREHAGRFLPDFMVPSAFTTIDAVPLTPGGKTDRAGLPDPVKATQPAGLGPRTPAEKVLCDIFRDLFDLVEIDVRSNFFEMGGNSILAVDLIQRAQEAGLTLMPRTVIDHPTIEQLAAIATLEE	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	107.91	gnl|BL_ORD_ID|4935|hsp_num:0	5928			117	1641	colistin A; colistin B
BGC0000834.1|Novobiocin_6 # 4882 # 6105 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.664	BGC0000834.1|Novobiocin_6 	4882	6105	+	Loose	680	27.335	LpeA	28.0	3004099	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCACCCGTCCCACGGTGTCCCCCAGCGAACTCGAACAGATCGACCTGGCATCACCGGTCCTGCACGCCGAGTACGAACTGGACGAGATCTTCCGCCACCTGCGCGCCGATGAGCCGGTGTACTGGCAGCAGCCACGGAACGAGCAGCCCGGCTTCTGGGTGATCAGTCGCCACGCCGACGTGAACGAGGTGTACAAGGACAAGGAGCACTTCACGACGGAGCACGGCAACGCGCTGGCCACTTTGCTGACCGGCGGTGACTCTGCCTCGGGCGCCATGCTCGCCGTCACCGACGGAGTGCGCCACCATCAGGTGCGCAACGTGTTGTCCAGGGGCTTCTCGGCGCGGATGCTCGACCTCATCGCCCACACGCTGCAGGAAACCGTGGACGGTCTGCTGCTGGCGGCACTGGAGCGAGGCGAATGCGACGCCGCGCAGGACATCGCGGCGGACGTGCCACTCGGGGCGATCTGCGACCTGCTGGAGATTCCCCACGCGGACCGGAAGTACCTGCTCGGTCTGACCTCGCACGCGTGGAGCACGGACTACGCGGACGAGCCTCCCGAGGAGAGCTGGGTCGCCAAGAACGAGATCCTGCTGTACTTCAGCAAGCTGCTCAAGGAGCGTCGCGGTGGAGTCCGGGAGGACATGGTCAGCCTGCTGGCGAACTGCCGGATCGACGGCGATCCGCTCAAGGCGGCCGAGCAGATGGCCAACTGCTACGGGCTGATGATCGGCGGCGACGAGACCGGCAGGCACGCCATCACCGGCACGATCCTCGCGTTGATCCAGAACCCCGACCAGTGGCGTGCGCTGAAGAACGGCGACGTCGATCTGAACACGGCGACCGAGGAGGCCCTGCGCTGGACCGTGCCGTCGCTGCACGGAGGCCGGAAGGCGACCGGAGACGTCGTGATCAACGGCCGGCGGATCAACGCCGGCGATGTGGTCAGTGTGTGGATCTCCTCGGCCAACCGTGACGAGACCGTCTTCGACGCGCCGGACGAGTTCAACCTCGCCCGCACCCCGAACAAGCACTTCACCTTCGCGTACGGCTCGCACTACTGCCTCGGCCACTACCTCGGCCGGATGGAGGTCTACGCCGTGCTCGACGGGCTGCGCCGGCTGGTGGGCGACCTGGAGCAGATCGGCGAGGAGCGATGGATCTACTCCAGCATCCTGCACGGGATGAGCTCACTGCCGATCAGGATCACGGGCTGA	MSTRPTVSPSELEQIDLASPVLHAEYELDEIFRHLRADEPVYWQQPRNEQPGFWVISRHADVNEVYKDKEHFTTEHGNALATLLTGGDSASGAMLAVTDGVRHHQVRNVLSRGFSARMLDLIAHTLQETVDGLLLAALERGECDAAQDIAADVPLGAICDLLEIPHADRKYLLGLTSHAWSTDYADEPPEESWVAKNEILLYFSKLLKERRGGVREDMVSLLANCRIDGDPLKAAEQMANCYGLMIGGDETGRHAITGTILALIQNPDQWRALKNGDVDLNTATEEALRWTVPSLHGGRKATGDVVINGRRINAGDVVSVWISSANRDETVFDAPDEFNLARTPNKHFTFAYGSHYCLGHYLGRMEVYAVLDGLRRLVGDLEQIGEERWIYSSILHGMSSLPIRITG	MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS	114.65	gnl|BL_ORD_ID|2386|hsp_num:0	2758			219	441	erythromycin; spiramycin; azithromycin
BGC0000834.1|Novobiocin_7 # 6119 # 6913 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=9bp;gc_cont=0.721	BGC0000834.1|Novobiocin_7 	6119	6913	+	Loose	700	26.5646	CMY-151	35.9	3005217	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	GTGCGGATGACGAGCCCGGCCGATGCGACCACCGAAGTCGCTGTGTCTCAGGAGTCGGTCGCCATGGTCACCGGAGCCGGCCGGGGCATCGGCGCGGCCACGGCCGAGCGCCTCGCCGCCGAGGGCATGGCGGTGATCGTCGTGGACCGCACCGAACAGGACACCCGGGCCACGGTCGCGGCCATTCGCACGGCCGGCGGACGGGCCCGCGGGATCGGCTGTGACGTCGCCGTGGCCCAGGCCGTGACGGCCGCGGTCGCCACGGCCGTCGAGGAGTTCGGCCGCATCGACGTACTGGTGAACTGCGCCGGGATCAACCGGGACCGGCTGCTGCTCACCATGGGCGATCAGGAGTGGGACACGGTCCTGGACGTCAACCTCGGCGGCACCATGCGATGTTCGTTCGCCGTCGGCCGGCACATGCGCCGGCAGGGGCACGGCCGGATCATCAACTTCAGCTCCGTGGCCGCGCGCGGCAATGCCGGCCAGACCAACTACGCGACCGCCAAAGGCGCGATCGCCGGGTTCACCCGTACGCTCGCGGCCGAACTGGGCCCGCACGGCGTGACGGTCAACGCCATCGCACCGGGCTTCGTGGCCACGCCGATGGTGGACGAGCTGGCCGAACGGCTCGGCGGGGACCGGGACTCGGTCATGTCGGAGGCGGCGAAGTCCTCGGCAGTGGGCCGGATCGGGACGCCCGAGGAAATCGCCGCGACCGTGGTCTTCGTCGCCCGGCCGGAATCGGGCTACCTCACCGGCGAGACCGTTCACGTCGACGGCGGTCGGCCATGA	MRMTSPADATTEVAVSQESVAMVTGAGRGIGAATAERLAAEGMAVIVVDRTEQDTRATVAAIRTAGGRARGIGCDVAVAQAVTAAVATAVEEFGRIDVLVNCAGINRDRLLLTMGDQEWDTVLDVNLGGTMRCSFAVGRHMRRQGHGRIINFSSVAARGNAGQTNYATAKGAIAGFTRTLAAELGPHGVTVNAIAPGFVATPMVDELAERLGGDRDSVMSEAAKSSAVGRIGTPEEIAATVVFVARPESGYLTGETVHVDGGRP	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISMLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ	69.29	gnl|BL_ORD_ID|2917|hsp_num:0	3934			588	705	
BGC0000834.1|Novobiocin_8 # 6910 # 7644 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGT;rbs_spacer=5bp;gc_cont=0.740	BGC0000834.1|Novobiocin_8 	6910	7644	+	Loose	600	25.0238	TriB	35.56	3003680	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACACGAGTGGCGGTCGTGGCCGGCGGCGGCGAGCACACGGGGCCCGCGGTCGCGCTCAGGCTGGCGGCGGGGGGCTTCGACGTCGCCCTGCTGGGCTCCGAGTTCACGTCGGCCGACAAGACGGTCAGGCGCGTCGAGGAGTACGGCAGGCAATGCGTCACCGTGCGGGCCGAGTTGAGCGACGCCAGATCCGTCGCGGTCGCCTTCGGCCGGGTACGTACGGCGTTGAGCGGCCCGGCCGTACTGGTCACCTGCGTCGGACCGCAGCCGCTGCCGGACGGGTTGCCCGAGGACGAGAGCGCGGACGAACAGCGCTACACGGCGGTACGGCGGGCGCTGCGCCCGGTGTTCGTGTGCTGCCAGGCCGGGGCCGGCCAGCTGCTGCGCCACCGGTGGGGACGGATCATCATCGTCACCGAGCCGGCCGACGCCGACGGGAACACCTGGCGCACCAGCCGGCCGGTGCTCGACGGGCTGATCGGTTTCACCCGGTCCGCGGCGCTGGAGCTGGCGAGGTCCGGGACCACCGTGAACCTCGTCGCTCCGGCCGACCGCGCCGCCGACAGCCGGGCCCCGGCCCACCGGGCGGCGGGCGACGACAGCGCGGGCTCCTACGCGGACGGGGTCGCGCACGTGACGGAGTTCCTGGTCGACGAGCGAGCCGTCGGAATCACCGGGCAGGCGATCCGTGTCGCCGCCCGGGCGGACGTACCTCTACTTCGCGAAAGGTAG	MTRVAVVAGGGEHTGPAVALRLAAGGFDVALLGSEFTSADKTVRRVEEYGRQCVTVRAELSDARSVAVAFGRVRTALSGPAVLVTCVGPQPLPDGLPEDESADEQRYTAVRRALRPVFVCCQAGAGQLLRHRWGRIIIVTEPADADGNTWRTSRPVLDGLIGFTRSAALELARSGTTVNLVAPADRAADSRAPAHRAAGDDSAGSYADGVAHVTEFLVDERAVGITGQAIRVAARADVPLLRER	MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLGFRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQEELFARSVTAQARLDDARTRLKTSQASFDQAKAAVQQARDQLSYTRLVTDFDGVITTWHAEAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIRELGPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWVVDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR	68.54	gnl|BL_ORD_ID|2003|hsp_num:0	2193			282	417	triclosan
BGC0000834.1|Novobiocin_9 # 7651 # 9234 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGGT;rbs_spacer=8bp;gc_cont=0.703	BGC0000834.1|Novobiocin_9 	7651	9234	+	Loose	1000	44.2838	almE	24.03	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGGCGAACAAGGATCACGCACCGGAGCACTACGTCACCCGCATCCTCGCCGAGGCGACCCTTGACGGCGCGCGACCGGTCGTCCGGTGGCGGGACACGGTCATCACCGGCACCCAACTCGACCGATCGGTACGGCGCGTCGTGACGGCACTGCGCGAGGCAGGTGTGGCACGCGATCACGCGGTGGCCGTCCTGACCCAGGTCAACAGTCCATGGATGCTGATCGTCCGCTACGCCGCGCACCTGGTGGGCGCGTCGGTCGTGTACATCACCGGCGCCAACCACGGCATCGTGACGCACGAACTGCCGGTGGCCACCCGGGTCCGGATGCTGCGTGAAGCGGGCGCGTCGGTGCTGGTGTTCGACGAGAGCAACGCCCAACTCGCCGAGACCGTCGACGAGACGGTGCGGGACAAGCTGGTGCTGTGCGGCCTCGGTCATCCGGCGTCCGGCACGGTGAGCGTCGACGGCCGGCCTGTCGATGACGTCTCGGTGGACTTCACGCCCGAGGCGCCCGAGCTGGCCATGGTGCTCTACACCAGCGGCACCACCGGTCAACCCAAGGGCGTGTGCCGGTCGTTCGGGTCGTGGAACGCGGCGGCGCTCCGCGGGGCGGCGTATCCCCGGCCGGTCTTCCTGACAATGACCGCGGTGAGCCAGACAGTCGCGATGATCGTCGACACGGTGCTGGCCGCCGGCGGGAGCGTGCTGCTGCGCGAGAGGTTCGATCCCGCCGACTTCCTGCGGGATGTCGGAGAGCACCGCGTCACCGAGACGTTCATGGGCGTGGCGCAGCTCTACGCGATCCTCGGGCACCCGGACGCTCGTACCGCGGACCTGTCCTCGTTGCGCCACGTGTTGTATCTCGGCTGCCCCGCGTCACCGGAACGCCTGCGGGAGGCGGCCGCACTGCTGCCCGGCGTACTGGCCCAGTCGTACGGCTCCACCGAGGCCGGCCGGATCACGGTGCTCCGCGCGGCCGACCACGAACGTCCGGAACTGCTGGCCACCGTGGGCCGGGCGGTGCCGGGGGTCACCATCGCCATCCGCGACCCGGAAACAGGACACGACCTGCCGGTCGGCGAGATCGGCGAGGTCGTGGTGCACGGCCCGGAGGTCATGGCCGGCTATGTCGCCGATCCCGAGCACACCGCGCGGGTGATCCGGGACGGCTGGGTGCACACCGGCGACTTCGGTTCCGTCGACGAACGCGGGTACGTGCGGCTGTTCGGCCGGATGCGCGAGGTGGTCAAGGTGCAGGACACGCGGGTCAGTCCGACCGAGGTGGAGAAGGTGCTCGTCGGCTGTCCCGGTGTGGTCGACGCGTGCGTGTACGGCCACCGCGGGCCGGACCTCATCGAGGAACTGCACGCCGCCGTCGTACTGGGCACCGAGGGCGCTCCGAGCTTTGACACTCTGCGCGACCACGTCGCCCGGGCCATGACCCCGACACACGCCCCGATCCGGTTCGTACGGTGGCGGCGGTTCCCGATCAACAACACCGGCAAGGTGAATCGGCTGCGGGTCCGAGAGGTCAGCGCCGAGGCCCGCGGTGACAGCCCGGACGTCCTGGTGGACAGGTGA	MANKDHAPEHYVTRILAEATLDGARPVVRWRDTVITGTQLDRSVRRVVTALREAGVARDHAVAVLTQVNSPWMLIVRYAAHLVGASVVYITGANHGIVTHELPVATRVRMLREAGASVLVFDESNAQLAETVDETVRDKLVLCGLGHPASGTVSVDGRPVDDVSVDFTPEAPELAMVLYTSGTTGQPKGVCRSFGSWNAAALRGAAYPRPVFLTMTAVSQTVAMIVDTVLAAGGSVLLRERFDPADFLRDVGEHRVTETFMGVAQLYAILGHPDARTADLSSLRHVLYLGCPASPERLREAAALLPGVLAQSYGSTEAGRITVLRAADHERPELLATVGRAVPGVTIAIRDPETGHDLPVGEIGEVVVHGPEVMAGYVADPEHTARVIRDGWVHTGDFGSVDERGYVRLFGRMREVVKVQDTRVSPTEVEKVLVGCPGVVDACVYGHRGPDLIEELHAAVVLGTEGAPSFDTLRDHVARAMTPTHAPIRFVRWRRFPINNTGKVNRLRVREVSAEARGDSPDVLVDR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	94.78	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1617	colistin A; colistin B
BGC0000834.1|Novobiocin_10 # 9248 # 10387 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGT;rbs_spacer=10bp;gc_cont=0.732	BGC0000834.1|Novobiocin_10 	9248	10387	+	Loose	700	64.3142	oleI	25.45	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAGAGTGCTGTTGACGAGTCTGCCCGGCATCGGCCACCTGTTTCCCATGGTGCCGCTGGGCTGGGCGCTCCAGGCGGCCGGGCACACCGTCCTGGTCGCCACGGACCGGGAGTTCCTCCCGGTGGTGACCGGGGCGGGACTGTCCGCCACGGCCGTACTGGACCCGGTCGACCCGGTCGAGCTGTTCAAACCGGTCGAACCGTTCGGCGATCCGCTGAGCCCGGCCGAGCGGACCGGGCACCGGTGCGCCGAGGCCGGTGTCCGGGCGCTGCCCGCCATGCGCGCACTCGTGGACGTGTGGCACCCGGACCTGGTGATCGCCGAGCCCATGGAGCTGGCCGGGCCCGCCGCGGCGACGAATGCCGGGGTGCCCTGGGTACGGCACTCCTACGGGCTGATCCCGCCGGGGCCGCTGCTGAGCGTCGCGGCCGAGGTTCTGGACGCCGAACTGGCGGTACTGGGGCTCTCCGCGCTGGCGAAACCGGCGAGGACGATCGACGTGTGCCCCGACAGCCTCCGGCCTTCGGACGGAGTGGCGACCGTGCCCATGCGGTACGTGCCCTACAACGGCCCGGCCGGCGTACCCGACTGGCTGTTGGCCGGGCCCCCTGCCCGGCCCCGGGTCTGCCTGACGCTGGGCACGTCCCTGCCCCGGCGTGATCCGCACGTGGCACCGCTGTGGCGGCTGCTGCTGGATGAACTGGTGGCCCTGGGCCAAGAGGTGGTCATCGCCATCGACGAGAGCCACCGGCCCCTGCTGGGCCACCTGCCCGACGGCGTGCGCGCCGCCCGGATCCCGCTCTGCGACCTGCTGCCGACGTGCACCGCGATCGTGCACCACGGTGGCTCGGGGAGCACCATGGCGGCGGCCTCCTTCGGTGTGCCGCAGCTGGTGGTTCCGCACTTCGCGGACCACTTCACCAACGCGGAGCGACTCACCGCCGTCGGCGCGGGTCTGAGCCTGCCGCACGACACCGACGACCTGGCACGGATCAGCGCGGCCTGCGAGCTGATCACCGGAGACGGCCCGCACCGCGCGATCTCACGCCGTCTCGCCGACGAGAACGCCCGCCGACCGACCCCGGCCGTGGTGGCCGAGGGCCTGGCGGCCGAACAACGGTCAATGACTCCCGCGTGA	MRVLLTSLPGIGHLFPMVPLGWALQAAGHTVLVATDREFLPVVTGAGLSATAVLDPVDPVELFKPVEPFGDPLSPAERTGHRCAEAGVRALPAMRALVDVWHPDLVIAEPMELAGPAAATNAGVPWVRHSYGLIPPGPLLSVAAEVLDAELAVLGLSALAKPARTIDVCPDSLRPSDGVATVPMRYVPYNGPAGVPDWLLAGPPARPRVCLTLGTSLPRRDPHVAPLWRLLLDELVALGQEVVIAIDESHRPLLGHLPDGVRAARIPLCDLLPTCTAIVHHGGSGSTMAAASFGVPQLVVPHFADHFTNAERLTAVGAGLSLPHDTDDLARISAACELITGDGPHRAISRRLADENARRPTPAVVAEGLAAEQRSMTPA	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	89.39	gnl|BL_ORD_ID|1684|hsp_num:0	1824			42	1167	oleandomycin
BGC0000834.1|Novobiocin_11 # 10416 # 12449 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	BGC0000834.1|Novobiocin_11 	10416	12449	+	Loose	200	26.1794	vanH gene in vanB cluster	30.91	3002943	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGCTCATTCTTGGCCTGAACGGGAATGTGTCCGCAGCGGGCGCCGATGTGGTGCCGAACCTCAACGAGCTCTACATGCACGACGCCGCCGCCACACTGGTCCGCGACGGAGTTCTCGTGGCGGCGGTGGAGGAGGAGCGGCTCAACCGGATCAAGAAGACGACGAAATTCCCCAGCAACGCGATCCGGGAATGCCTCGCCGCCGCGGGTGCGAAACCGGCGGACGTCGACGCGATCGCCTACTACTTCCCCGAAGACTTCTTCGACGACATATTCCAGCAGCTCTACACCGAGCATCCGAGCGTGCCGACGCGGTACTCGCGCGAGATGATCCTGGAGCGTCTTCGCGTCGACCTCGGCTGGGCGGCTCCGCCGGACATCCTCCACTACGTGCCGCACCACCTGGCCCACGCGATGTCGACGTACTACCGGTCGGGCATGCGCGAGGCACTGGTCGTCGTCATGGACGGGGCGGGTGAGCGCAACTGCACCACGATCTACCGGTCGGACGGGGCCGAGCTGTTCGAGATCGCGTCGTACCCGGTGCCGAAGTCGCTCGGCATGTTCTACCTGTACGGGACCAGACACCTCGGCTACGGCTTCGGCGACGAGTACAAGGTGATGGGCCTCGCCCCGTACGGCGACCCGTCCACCTACCGCGACGTCTTCTCGACCCTGTACTCGCTCGGTCCGAACGGCACCTACGAGTTGATCCCGCGCGGGGGAGTGGTCTTCAGGATGACCACGATCCTGCGGGAGCACGGTCTCCAACCCCGCCGTCGCGGTGAGCCGTTCACCCAGGCGCACATGGACTTCGCGGCGAGTGTGCAGGAGACCACCGAGCAGATCGCGATGCACGTGATCGGCTACTGGGCACGCTCCACGGGCCTGCGGAACCTGGCCTTCGGTGGCGGCGTCGCCCACAACTCGACGCTCAACGGCCGCATCCTCACCTCCGGCCTGTTCGACGAGGTGTTCGTCCATCCGGCGTCGCACGACGCCGGATCCAGCGAGGGCGCCGCACTCGTGGTCGCGCGGGAACGCGGCGAACGCGTATGGCCGCTGCCCCGGTTGACGAACGCGAGCCTCGGCCCGGATCTGGGCGACGTCGACTCGCTGGAGCGGACGCTCAAGTCGTGGAGCCCGCTCGTCGACGTCGAGCGTCCCGACGACATCGTCGAGGCCACCGCGCACCTGCTCGCTGCCGGCGAGGCGATCGGCTGGGCGCACGGCCGCTCGGAGTTCGGGCCGCGCGCGCTGGGCAACCGCAGCATCCTCGCCGACGCGCGCCCCAAGGAGAACCAGACGCGCATCAACGCCATGGTGAAGAAGCGCGAGAGCTTCCGCCCGTTCGCCCCGGTCGTGACCGCGGAGGCGGCCGGTGACTACTTCGATCTGCCGGAGACCGTGGGACACCACGACTTCATGTCGTTCGTCGTGCAGGTGCGGGCGGACCGCCGGGAGTTGCTCGGCGCGGTGACCCATGTCGACGGCAGCGCGCGCGTCCAGGTCGTCACCGAGGAGACGAACCCGCGATTCCACCGGCTCGTCACGCGCTTCGGTGAGTTGACCGGCACCCCCGTGCTGCTCAACACCTCGTTCAACAACCACGCCGAGCCGATCGTGCAGTCCGTCGATGACGTCCTCACGAGCTATCTCACGACGAGCCTCGACGTGCTCGTGATCGAGGACTTCGTGGTTCGCAGGCGGACCGAACTGCCGCTGGCGCTGGAGGACTTCACCATCGGCTTTCGCCCGGTGACCAGGCTCGTCCGCCGGCTCGCCGACGTGTCGGCGGGCAGGCCGGGCGCTCCCGAGGTCTCGCACGAGATCTACCTCGACCACACCTCCGGACCGCGTGCGACGATCTCGGCCGCCATGTACGAGCTGCTCACCCACGCCGACGGTGTCACCCCGCTGGGCAGCCTCGGCATCGAGCTGACCGGAGAGCTCCTGACAGAGCTGTACGACCTGTGGCAGGGGCGCTTCGTCACCGTCGCCCCCGTGGGGGACGGTGCCGGATCCGCACCGTGA	MLILGLNGNVSAAGADVVPNLNELYMHDAAATLVRDGVLVAAVEEERLNRIKKTTKFPSNAIRECLAAAGAKPADVDAIAYYFPEDFFDDIFQQLYTEHPSVPTRYSREMILERLRVDLGWAAPPDILHYVPHHLAHAMSTYYRSGMREALVVVMDGAGERNCTTIYRSDGAELFEIASYPVPKSLGMFYLYGTRHLGYGFGDEYKVMGLAPYGDPSTYRDVFSTLYSLGPNGTYELIPRGGVVFRMTTILREHGLQPRRRGEPFTQAHMDFAASVQETTEQIAMHVIGYWARSTGLRNLAFGGGVAHNSTLNGRILTSGLFDEVFVHPASHDAGSSEGAALVVARERGERVWPLPRLTNASLGPDLGDVDSLERTLKSWSPLVDVERPDDIVEATAHLLAAGEAIGWAHGRSEFGPRALGNRSILADARPKENQTRINAMVKKRESFRPFAPVVTAEAAGDYFDLPETVGHHDFMSFVVQVRADRRELLGAVTHVDGSARVQVVTEETNPRFHRLVTRFGELTGTPVLLNTSFNNHAEPIVQSVDDVLTSYLTTSLDVLVIEDFVVRRRTELPLALEDFTIGFRPVTRLVRRLADVSAGRPGAPEVSHEIYLDHTSGPRATISAAMYELLTHADGVTPLGSLGIELTGELLTELYDLWQGRFVTVAPVGDGAGSAP	MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEVSEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSRKIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGSLVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTERVLRDTTEKTIRNCLNFERSLQHE	209.60	gnl|BL_ORD_ID|4673|hsp_num:0	626			477	642	vancomycin
BGC0000834.1|Novobiocin_13 # 12680 # 13372 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=7bp;gc_cont=0.674	BGC0000834.1|Novobiocin_13 	12680	13372	+	Loose	600	35.8094	emtA	46.15	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; orthosomycin antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGAAGATTGAAGCGATTACGGGATCCGAGGCCGAAGCATTTCACCGGATGGGGTCCCAGGCGTCCCACAGGTACGACGAATTCGTGGATCTGCTTGTCGGGGCCGGCATCGCCGACGGCCAGACCGTGGTCGACCTGTGCTGTGGCTCGGGCGAGCTGGAAGTCATCCTCAGCTCCCGGTTCCCCTCGCTGAATCTGGTCGGTGTCGACCTCTCGGAGGACATGGTCCGTATCGCCCGGGAGTACGCGGCCGAGCAGGGCAAGGCGCTCGAATTCCGGCACGGCGACGCGCAACTCCTGGCCGGTATGGAGGATCTGGCCGGGAAAGCGGACCTGGTGGTCTCGCGGAACGCGTTCCACCGGCTCACCCGGCTGCCGGCGGCGTTCGACACCATGCTGCGCCTGGCCAAGCCGGGAGGGGCCGTCCTCAACTGCTCCTTCATACACCCGAGCGACTTCGACGAGTCCGGGTTCCGGGCGTGGGTCACGTTCCTCAACCAGCGGCCCTGGGACTCGGAGATGCAGATCGTCTGGGCGCTGGCTCACCATTACGCGCCCCGGCTCGACGACTACCGCGAGGCCCTGGCCCAGGCGGCCCGTGAGACGCCGGTGTCCGAGCAGCGCGTCTGGATCGACGACCAGGGATACGGCGTTCCCACGGTCAAATGCTTCGCCCGCCGGGCCGCCGCCTGA	MKIEAITGSEAEAFHRMGSQASHRYDEFVDLLVGAGIADGQTVVDLCCGSGELEVILSSRFPSLNLVGVDLSEDMVRIAREYAAEQGKALEFRHGDAQLLAGMEDLAGKADLVVSRNAFHRLTRLPAAFDTMLRLAKPGGAVLNCSFIHPSDFDESGFRAWVTFLNQRPWDSEMQIVWALAHHYAPRLDDYREALAQAARETPVSEQRVWIDDQGYGVPTVKCFARRAAA	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	67.45	gnl|BL_ORD_ID|2212|hsp_num:0	3368			576	684	evernimicin
BGC0000834.1|Novobiocin_14 # 13429 # 14205 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGGGT;rbs_spacer=10bp;gc_cont=0.631	BGC0000834.1|Novobiocin_14 	13429	14205	+	Loose	500	28.1054	OXA-243	23.08	3001610	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGAAACCGCGAAGGAAACGAACAGCGACTCATCGCTGTATCTGGACCTCATGATCAAAGTGCTGGCCGGGACGGTGTACGAGGATCCCGCGCACCGGGAGAACTTCTCGCACCGCGATTCGACGTACCGGGAAGAAGTCCGCAACGAGGGACGCGACTGGCCCGCGAACGCACACACGATGATCGGAATCAAACGCCTCGAGAACATCCGGCAATGTGTCGAGGACGTCATCGGCAACAACGTACCCGGCGACCTCGTGGAAACCGGCGTATGGCGTGGGGGAGCCTGCATCCTCATGCGGGGAATTCTGCGCGCCCATGACGTGCGGGACCGCACAGTCTGGGTCGCCGACTCCTTCCAGGGCATTCCCGACGTCGGTGAGGACGGCTACGCCGGCGACCGGAAGATGGCGCTGCACCGGCGAAACTCGGTGCTCGCGGTCTCCGAGGAAGAGGTCCGGCGCAACTTCCGCAACTACGACCTGCTGGACGAACAGGTCCGGTTCCTTCCCGGCTGGTTCAAGGACACGCTGCCCACCGCGCCGATCGACACGCTCGCCGTGCTGCGGATGGACGGGGACCTGTACGAATCCACCTGGGACACCCTGACCAATCTCTACCCGAAGGTGTCCGTCGGTGGCTATGTCATCGTCGACGACTACATGATGTGCCCGCCGTGCAAGGACGCGGTCGACGAATACCGCGCGAAGTTCGACATCGCCGACGAACTGATCACGATCGACCGCGACGGTGTCTACTGGCAACGCACCCGGTAA	METAKETNSDSSLYLDLMIKVLAGTVYEDPAHRENFSHRDSTYREEVRNEGRDWPANAHTMIGIKRLENIRQCVEDVIGNNVPGDLVETGVWRGGACILMRGILRAHDVRDRTVWVADSFQGIPDVGEDGYAGDRKMALHRRNSVLAVSEEEVRRNFRNYDLLDEQVRFLPGWFKDTLPTAPIDTLAVLRMDGDLYESTWDTLTNLYPKVSVGGYVIVDDYMMCPPCKDAVDEYRAKFDIADELITIDRDGVYWQRTR	MTVRLSSTALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPASTFKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPLKAAAYDLAENLFEVGEAGGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVFARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK	93.82	gnl|BL_ORD_ID|599|hsp_num:0	655			261	651	cloxacillin; oxacillin; cefalotin
BGC0000834.1|Novobiocin_15 # 14235 # 15206 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.691	BGC0000834.1|Novobiocin_15 	14235	15206	+	Loose	500	26.5646	OXA-114q	30.43	3005716	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCCGCACTCCCGATGAATCAAGAATTCGACCGCGAACGCTTTCGCGTCGATTTACGCGCCACCGCCGCCGCGATCGGCGCGCCCGTCACCCCCCGTGTCACCGACACGGTCCTCGAGACCTTCCGTGACAACTTCGCCCAGGGCGCCACCCTGTGGAAGACCACCAGCCAGCCCGGGGACCAGCTGTCGTACCGGTTCTTCTCCCGTCTCAAGATGGACACCGTCGGCCGGGCCGTCGACGCCGGGCTGCTCGACGGCACACATCCGACCGTGCCCATCGTCGAGGACTGGAGCGACCTCTACGGCGGCACGCCCGTGCAGTCGGCCGACTTCGACGCCGGGCGGGGAATGGCCAAGACCTGGCTGTACTTCGGCGGCCTGCGGCCGGCCGAGGACATCCTCTCCGTCCCCGCACTGCCGGCGCCGGTACAGGCCCGGCTGAAGGACTTCCTCGGACTGGGCCTGGCACATGTCCGGTTCGCGGCGGTGGACTGGCGCCACCGGAGTGCGAACGTCTACTTCCGCGGTCAAGGCCCCCTGGACACCGCTCAGTTCGCCCGCGTCCACGCCCTGTCCGGCGGCACACCACCCGCCGCGGATGTCGTGGCGGAGGTCCTCGCGTACGTGCCCGAGGACTACTGCGTCGCCATCACCCTCGACCTGCACACCGGCGCCATCGACCGGGTGTGCTTCTACGCCCTGAAGGTCCCCAAGGACGCGCGGCCACGCGTCCCCGCCCGCATCGCCACGTTCCTCGAGGTCGCGCCCAGCCACGACCCGGAGGAGTGCAACGTCATCGGCTGGTCGTTCGGCCGCAGCGGCGACTACGTCAAGGCCGAACGCAGCTACACCGGGAACATGACGGAGATCCTGTCCGGCTGGAACTGCTTCTTCCACGGCGAGGAAGGCCGCGACCACGACCTGCGCGCGCTTCAAGACACCGGATCGATCACCGGAGGTGCCCGATGA	MPALPMNQEFDRERFRVDLRATAAAIGAPVTPRVTDTVLETFRDNFAQGATLWKTTSQPGDQLSYRFFSRLKMDTVGRAVDAGLLDGTHPTVPIVEDWSDLYGGTPVQSADFDAGRGMAKTWLYFGGLRPAEDILSVPALPAPVQARLKDFLGLGLAHVRFAAVDWRHRSANVYFRGQGPLDTAQFARVHALSGGTPPAADVVAEVLAYVPEDYCVAITLDLHTGAIDRVCFYALKVPKDARPRVPARIATFLEVAPSHDPEECNVIGWSFGRSGDYVKAERSYTGNMTEILSGWNCFFHGEEGRDHDLRALQDTGSITGGAR	MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQSTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLPVKAAAYELAENLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVYARLLQDERATRPNAGLRARDELVRDWPAKAGAWRP	117.45	gnl|BL_ORD_ID|3746|hsp_num:0	4816			69	276	cloxacillin; oxacillin; cefalotin
BGC0000834.1|Novobiocin_16 # 15203 # 16015 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGT;rbs_spacer=5bp;gc_cont=0.691	BGC0000834.1|Novobiocin_16 	15203	16015	+	Loose	600	25.0238	ICR-Mc	28.26	3004466	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	intrinsic colistin resistant phosphoethanolamine transferase	ATGAGCGAGGCTCTGGCGAACATGCCCGGAGACGACTACTTCCGTCAGCCGCCGGTGTTCGACACCTACGCCGAGCACCGCGCCTATCTCAAGTTCCGGCACGCCGTCGCGCTGCGGCACTTCGCCCGCCTCGGCTTCGACCAGGACGGCCTCGCCGGACTGATCACCGTCGCCGACCCGGAACACGCCGACACCTACTGGGCCAATCCGCTGGCCCACCCCTTCTCCACCATCACACCGGCGGACCTGATCCGCGTCGACGGCGACAGCGCCGAGACCGTCGAAGGCCAACGCCGGGTCAACATCGCCGCGTTCAACATCCACGCCGAGATCCACCGCGCACGCCCCGACGTCCAGGCCGTCATCCACCTGCACACCGTCTACGGCCGAGCCTTCTCCGCCTTCGCCCGCAAGCTCCCTCCGCTGACCCAGGACGCGTGCCCGTTCTTCGAGGACCACGAGGTGTTCGACGACTTCACGGGTCTGGTGCTCGCCAAGGACGACGGGCGCAGGATCGCGAAACAGCTGCGCGGGCACAAGGCGATCCTGCTGAAGAACCACGGTCTGGTCACCGTCGGGGAGACACTCGACGCGGCCGCCTGGTGGTTCACGCTCCTGGACACCTGCTGCCATGTCCAGCTGCTGGCGGACGCGGCCGGGAAGCCGGAGGAGATCCCCGCGGAGGTCGCACGCCTGACGGGCCGGCAGCTCGGCTCGCACCTGCTGGGCTGGAACAGCTACCAGCCCCTGCACGAGGCAGCCCTGGCCCGTGACCCCGACCTGGCGACCATGGAGCCCGCGCTCCCGTCATGA	MSEALANMPGDDYFRQPPVFDTYAEHRAYLKFRHAVALRHFARLGFDQDGLAGLITVADPEHADTYWANPLAHPFSTITPADLIRVDGDSAETVEGQRRVNIAAFNIHAEIHRARPDVQAVIHLHTVYGRAFSAFARKLPPLTQDACPFFEDHEVFDDFTGLVLAKDDGRRIAKQLRGHKAILLKNHGLVTVGETLDAAAWWFTLLDTCCHVQLLADAAGKPEEIPAEVARLTGRQLGSHLLGWNSYQPLHEAALARDPDLATMEPALPS	MSLKHNQTHNTTFTKFLKSNSFWSKGFWSNRHHRTKDLKGLDAYLFMAIVAIFLTTTANVTFFQQVMSVYPLANYAPFIASLAVVLTGVLLLLLVLLGYRHTLKTVAICFILIAAFAGHFTDTYGTVYDTTMLQNALQTDTAETKDLLSMKLLIRVVLLAGLPICWIIGQPLSFGTLKASLMKRLVTYLVALALVGLPILAFSSQYASFFREHKPLRFFTNPVTVMYSAGKLANMSYKNATKPTETIMHANDAIQKTTASTRKPRLVVMVVGETARADHASFNGYQRATFPHMDKLIGLGQVHNFGNVTSCGTSTAYSVPCMFSYLGAEKYDVDTADYHENVIDTLDRLGVAILWRDNNSDSKGVMNRLPAKQYQDYKNSPLQGGNNTICHTNPYDECRDVGMLVDLDDHVKAHANQDILIVLHQMGNHGPAYYKRYDDEFAQFLPVCTSSELAECERQTVINAYDNALLATDDFLKQTIDWLAAQTHADTAMLYLSDHGESLGEKGVYLHGMPKAFAPKEQLSIPALLWLGADTPFAVANSPTAGFSHDAITPTLLNLFDVSTQATADKTAFVNPLD	46.71	gnl|BL_ORD_ID|2509|hsp_num:0	2902			1227	1500	colistin A; colistin B
BGC0000834.1|Novobiocin_18 # 16912 # 17922 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=6bp;gc_cont=0.672	BGC0000834.1|Novobiocin_18 	16912	17922	+	Loose	1200	28.4906	arnA	22.57	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCGAATTCTGGTGACGGGCGGCGCCGGCTTCATCGGCTCGGAATTCGTCCGGGCCACCTTGCGCGGAACTCTGCCGGGCTCATCGGGAACTCAGGTCACCGTTCTGGACAAGTTGACGTACTCCGGCAACGTGCTGAACCTCGCGCCGATCGCGGACCTGCGCAACTACCGTTTCGTGCGGGGCGACATCTGTGATCAGGACCTGGTGGACGACGTGGTCGCCGGTCACGACGCGATCGTGCACTTCGCCGCCGAGACACATGTGGACCGCTCGATCGGCAGCGCCGCCTCGTTCGTCCGCACGAACGCGATGGGCACCCAGGTACTGCTCGAAGCGGCCTCCCGCCACCGGCTGGGACGGTTCGTTCACATCTCGACCGACGAGGTGTACGGATCGATCCCCGAGGGCGCCTGGGACGAGGAGTCCCCGGTGGCCCCGAACGCCCCGTACGCGGCGGCCAAGGCGGCGGGAGACCTGCTGGCGCTGGCCTGGCACCGGACCCACGGGCTCGACGTCGTGGTCACCAGGTGCACCAACAACTACGGGCCGTACCAGTATCCGGAGAAGCTGATCCCGCTGTTCACGACCAACGTGATGGACGGTCAGCAGGTCCCGGTGTACGGCGAGGGCCACAACCGCCGGCAGTGGCTGCACGTCTCGGACCACTGCCGCGCCATCCAGCTGGTGCTCCTCGGTGGCCGGGCCGGGGAGGTCTACCACATCGGCGGTGGCACCGAGTTGACCAATCTCGAACTGGCCGAACAGATCCTGAAGTCCTGCGGTGCCGGCTGGGACATGGTCCGGCACGTGCCGGACAGGCCGGGGCACGATTTCCGCTACTCCCTGGACACCACCAAGATCCGTACAGAACTCGGTTTCTCGCCCCGGGTCGCGTTCGCGGACGGGCTGGTGGAGACCGTGGAGTGGTATCGCGACAACCGGGCCTGGTGGGAACCGCTCAAGAGTCCCGACGAAGCCACGGGTTCACCCGGCGACGCCGGCAGATGA	MRILVTGGAGFIGSEFVRATLRGTLPGSSGTQVTVLDKLTYSGNVLNLAPIADLRNYRFVRGDICDQDLVDDVVAGHDAIVHFAAETHVDRSIGSAASFVRTNAMGTQVLLEAASRHRLGRFVHISTDEVYGSIPEGAWDEESPVAPNAPYAAAKAAGDLLALAWHRTHGLDVVVTRCTNNYGPYQYPEKLIPLFTTNVMDGQQVPVYGEGHNRRQWLHVSDHCRAIQLVLLGGRAGEVYHIGGGTELTNLELAEQILKSCGAGWDMVRHVPDRPGHDFRYSLDTTKIRTELGFSPRVAFADGLVETVEWYRDNRAWWEPLKSPDEATGSPGDAGR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	50.76	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1764	polymyxin B
BGC0000834.1|Novobiocin_19 # 17974 # 19236 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=9bp;gc_cont=0.652	BGC0000834.1|Novobiocin_19 	17974	19236	+	Loose	500	33.113	ErmD	28.85	3000495	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCAGGACATAGTGCGGCCCATCGACGAGTGCCGGGTGTGCGGACACGACGATTGGCTCGATGTCGTCTCGTTCGGGTCGACGCCACTGGCCGGAAACCTGCTCGGCGACGAAGACGACGCGGGGGGCGAGACCCTGTTCCCGCTGGACGTCGTGGTGTGCCGGCGATGCTGGCTGATGACGCTGCGCCATGTCATCGAACCGGACGTCCTCTTCGGTCACTACCGTTACGTCGCCTCGGACGCGGGCTCGATCATCCAGCACATGCGGAAGCTCGTCGACCTGTGTGTCGAGCGGATCGGACTGACCGACGGAGACCTCGTCGTGGAGTTCGGCAGCAACACCGGCGCGCATCTGGAGCTGTTCCGGCAGGCCGGCCCCCGGGTGGTCGGCGTCGATCCCGCGCGCAATCTCGCGGGTGTCGCCAACGACCGCGGCGTGGAAACGATCCCCGCCGGTTTCACCGCCGAAGTCGGTGAGGAGATCGCGACCAGGCACGGCCTGGCACGACTGGTGTACGGGCGCCAGTGCTTCGCCCATATCCCGGACATCCACGAAGTCCTCAACGGGGTATCGGCCCTGCTGGCTCCAGACGGTCTGTTCTTCGTGGAAGTTCCCTATCTGGTGGAACTGCTCAAGAACAATCAGTTCGACACCATCTTCCACGAACACTTCTCCTACTTTTCGCTCGGCTCCCTGTGCACGCTGTTCGAGTCGCACGGCCTGCGCGTCGTGGACGTCCATACGGCCGATGTGCACGGCGGCTCGATCGTGGTCTTCGCCGCCCCGGCCGCCGCCGACCACGAGGTGCGGCCGGCCGTCGCCGAGATGCTCGCGGAAGAGCGGAGCCAGGGCATCGCGGAGGAGCGGACCTACCGGGAGTTCGCCGATCGTACGGAACGGGTGCGCGCACAGATCCGGGAACTGGTACGCGGCGTGGTGGCGGACGGCAAGACCGTGGCGGGATACGGCGCACCGACCAAGGGCAGCGCACTGCTGGCCGCCTGCGGGCTCGGACATCAGGAGATCCGGTTCTGCAGCGACACAACCGTTCTCAAGCAGGGGAAAATACTTCCGGGGTCCAGAATTCCGATCTGGTCACCGGAACAGGCGGCCGGCCATGTACCGGACTACTACCTGCTGTTGGCCTGGAACTACGCACCGGAGATCATCGACAACGAGAAGGAATTCCTGGAGAACGGCGGCCGATTCATCGTTCCCATACCCGAACCGCGGGTGATATCGGCGGAGTCGACGCTGTGA	MQDIVRPIDECRVCGHDDWLDVVSFGSTPLAGNLLGDEDDAGGETLFPLDVVVCRRCWLMTLRHVIEPDVLFGHYRYVASDAGSIIQHMRKLVDLCVERIGLTDGDLVVEFGSNTGAHLELFRQAGPRVVGVDPARNLAGVANDRGVETIPAGFTAEVGEEIATRHGLARLVYGRQCFAHIPDIHEVLNGVSALLAPDGLFFVEVPYLVELLKNNQFDTIFHEHFSYFSLGSLCTLFESHGLRVVDVHTADVHGGSIVVFAAPAAADHEVRPAVAEMLAEERSQGIAEERTYREFADRTERVRAQIRELVRGVVADGKTVAGYGAPTKGSALLAACGLGHQEIRFCSDTTVLKQGKILPGSRIPIWSPEQAAGHVPDYYLLLAWNYAPEIIDNEKEFLENGGRFIVPIPEPRVISAESTL	MKKKNHKYRGKKLNRGESPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTTVLSQKAGKVLAVENDSKFVDILTRKTAQHSNTKIIHQDIMKIHLPKEKFVVVSNIPYAITTPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHFSPPPKVDSAMVRITRKKDAPLSHKHYIAFRGLAEYALKEPNIPLCVRLRGIFTPRQMKHLRKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI	146.34	gnl|BL_ORD_ID|1022|hsp_num:0	1117			63	219	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000834.1|Novobiocin_20 # 19298 # 20191 # 1 # ID=1_20;partial=00;start_type=TTG;rbs_motif=GGGGGT;rbs_spacer=6bp;gc_cont=0.671	BGC0000834.1|Novobiocin_20 	19298	20191	+	Loose	200	35.4242	FosX	26.67	3000198	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	TTGAGGGGAATCCTGCTCGCGGGCGGTACCGGCTCCAGGCTGTGGCCGGTCACCCGCGCCATCTCCAAGCAGCTGATACCGGTCTTCGACAAGCCGATGATCTACTACCCGCTGACCACGCTGATGATGGCCGGCGTACGCGAGATACTCGTGATCACGCGCCCCGACGACCAGCGCCAGTTCCGTCATCTCCTCGGCGACGGCTCGCAACTGGGCCTGCGCCTCGAGTACGCCGTCCAGGAGCGGCCCGAGGGCATCGCGCAGGCGTTCGTCCTGGGCGCCGAGTTCATCGGCGACCAGTCGGTGGCCCTGGTCCTCGGGGACAACATCTTCCACGGCGCGGGCCTGGGAACCCGGCTGCGGCAGTACAACGACCCCGCCGGGGCCCGGATCTTCGCCTACGTCGTGGCCGACCCCAAGGCGTACGGGGTGGTGGAGTTCGACGAGGCCGGAAGGGCCGTCTCCATAGAGGAGAAGCCGGCGCGTCCCAAGTCGCGGTACGCCGTACCGGGGTTGTACTTCTACGACAACCGGGTGCTGGATGTCGTCCACGGCCTGGTGCCGAGCCGGCGCGGCGAACTGGAGATCACCGCCGTCAACGAAACGTATCTGAAGTGGGGCCAGTTGCGGGTCACCACGCTCGACCGGGGCACCGCCTGGCTGGACACGGGAACGTTCGCCTCCTTGGTCCAGGCATCGGAGTACGTACGAGTCGTGGAGGAACGGCAGGGCCTCAAGATCGGCTGCGTGGAGGAGGTCGCCTGGCGCTGCGGCTTCATCGGGAACGACCAGTTGCGGGATCTCAGCCGCCCGCTGCTCAAGAGCGGCTACGGCCGGTACCTCCTCGATCTGCTCGCCGATCACGAGGAGTTGAAGGAGGTGAAGCCGTCGTGA	MRGILLAGGTGSRLWPVTRAISKQLIPVFDKPMIYYPLTTLMMAGVREILVITRPDDQRQFRHLLGDGSQLGLRLEYAVQERPEGIAQAFVLGAEFIGDQSVALVLGDNIFHGAGLGTRLRQYNDPAGARIFAYVVADPKAYGVVEFDEAGRAVSIEEKPARPKSRYAVPGLYFYDNRVLDVVHGLVPSRRGELEITAVNETYLKWGQLRVTTLDRGTAWLDTGTFASLVQASEYVRVVEERQGLKIGCVEEVAWRCGFIGNDQLRDLSRPLLKSGYGRYLLDLLADHEELKEVKPS	MISGLSHITLIVKDLNKTTAFLQNIFNAEEIYSSGDKTFSLSKEKFFLIAGLWICIMEGDSLQERTYNHIAFQIQSEEVDEYTERIKALGVEMKPERPRVQGEGRSIYFYDFDNHLFELHAGTLEERLKRYHE	223.31	gnl|BL_ORD_ID|111|hsp_num:0	129			72	381	fosfomycin
BGC0000834.1|Novobiocin_21 # 20188 # 20811 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=AGGT;rbs_spacer=9bp;gc_cont=0.710	BGC0000834.1|Novobiocin_21 	20188	20811	+	Loose	700	25.7942	LHK-6	30.3	3006940	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	LHK beta-lactamase	GTGAGACTTCGCCCGCTCGGTATCGAGGGTGTCTGGGAGATCACCCCCGAGCAGCGCGCCGATCCGCGGGGGGTCTTCCTGGACTGGTATCACGTCGACCGGTTCGCCGAGGCGATCGGCCGCCCCCTGCGGCTGGCCCAGGCCAATCTGTCGGTGTCCGTCCGCGGGGTGGTGCGCGGCATCCACTTCGTCGATGTGCCGCCGGGGCAGGCCAAGTACGTGACGTGTGTGCGCGGCGCGGTGTTCGACGTGGTGGTGGACCTGCGCGTCGGCTCGCCGACGTACGGGTGCTGGGAAGGCACCCGGCTCGACGATGTCAGCCGTCGTGCCGTCTACCTCTCGGAGGGCATCGGGCACGGCTTCTGCGCGATCTCGGACGAGGCCACGCTGTGCTATCTGTCTTCGGGGACCTACGACCCGGCGACCGAGCACGGTGTGCACCCGCTCGATCCCGAACTGGCCATCGACTGGCCCACCGGGACGCCGCTGCTGTCCCCCCGCGACCAGGACGCGCTCCTGCTCGCCGAAGCCCGGGACGCCGGCCTGTTGCCGACCTACGCGACCTGTCAGGCCGTCACGGTGCCTTCACCGGCGCCGGGTTCGGTCGGAGACCCGGGCCCGTGA	MRLRPLGIEGVWEITPEQRADPRGVFLDWYHVDRFAEAIGRPLRLAQANLSVSVRGVVRGIHFVDVPPGQAKYVTCVRGAVFDVVVDLRVGSPTYGCWEGTRLDDVSRRAVYLSEGIGHGFCAISDEATLCYLSSGTYDPATEHGVHPLDPELAIDWPTGTPLLSPRDQDALLLAEARDAGLLPTYATCQAVTVPSPAPGSVGDPGP	MKKRITPFSRFASKGLSACSAGMLLVTVAHAANTAAAPAGMDAMVQTVMQAHQIPGMAIAIIQPGKTTYHNYGIASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASRYVTALRGSAFDRITLRQLGTYSAGELPLQFPDNVTTPADVLAYYRHWQPVHPAGTTRLYSNPSIGLMGLAASQATGESFAGLLGTTVLQPLGMNSTYLQVPPEARSRYAMGYTAAGKPVRVSPGPLDEETYGVKSTTADMAGFLLAHMDPARSKGALRSALQQTRVPVYCAGQTRQGLGWESYQDWKNLDVLLAGNSNQMVFEPQPVKACLAGTSNEPDVWVNKTGSTAGFGAYAVFLPARQAGIVILANRNYPIADRIRLAHGILTALH	53.08	gnl|BL_ORD_ID|3681|hsp_num:0	4751			333	432	
BGC0000834.1|Novobiocin_22 # 20773 # 21141 # -1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0000834.1|Novobiocin_22 	20773	21141	-	Loose	2000	25.0238	Staphylococcus aureus mupB conferring resistance to mupirocin	29.41	3000510	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	GTGCGGGAAGCAGCCGGAGAACTGGGGGGGAGAGGCGCGGCACGGCAGCCCGACCTGGGCCCCGGGGCTCGCGAAACCCTCGGGACGCCGGCCGCCGCCGACCATCGGGACGCTGAAGACAATACCGACGCCACCCCTTGCCGCCGGAACGAGAGCACCTCTGCGCGCCGCCGTGCGGCTCCCGCACCACATAAGTCGATCCCCCCTGCCTTCCCCTGTCGAAAAGACGGGAGAGGGCCGCCTGAAGGGTTCCCTGACGCCTTGCCGGACAGCGTCCCGGACACTATTTCCGACATGACCCTCCGCAGTCGCCAGTCGCGCTGCGTCAGATCACGGGCCCGGGTCTCCGACCGAACCCGGCGCCGGTGA	MREAAGELGGRGAARQPDLGPGARETLGTPAAADHRDAEDNTDATPCRRNESTSARRRAAPAPHKSIPPAFPCRKDGRGPPEGFPDALPDSVPDTISDMTLRSRQSRCVRSRARVSDRTRRR	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	11.81	gnl|BL_ORD_ID|4698|hsp_num:0	2271			780	933	mupirocin
BGC0000834.1|Novobiocin_23 # 21185 # 23218 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	BGC0000834.1|Novobiocin_23 	21185	23218	+	Loose	1000	654.055	Clostridioides difficile gyrB conferring resistance to fluoroquinolones	53.71	3004562	protein variant model	V423F	n/a	fluoroquinolone antibiotic	antibiotic target alteration	fluoroquinolone resistant gyrB	GTGACTTCTTACGACACCCGCACCGCCACCGACACCCCCGGACCCCAACTGCCCGGCCAGGTGGGGACGGCGTCGTACGACGCCGACGCGATCACCGTGCTGGACGGCCTGGACGCCGTACGCAAGCGGCCCGGGATGTACATCGGCTCCACGGGGGAGCGGGGGCTCCATCACCTGGTGCAGGAACTCGTGGACAACTCGGTGGACGAGGCACTCGCGGGGGTGGCCGACCGGATCGACGTGACGGTCCTGGCCGACGGCGGGGTGCGGGTGGTCGACAACGGCCGCGGCATCCCGGTGGGGATGCACCCGGTGGAGAAGCGGCCGGCCGTCGAGGTCGTACTGACCGTGCTGCACGCGGGCGGGAAGTTCGGGGGCGGCGGGTACACGGTCTCCGGCGGACTGCACGGCGTGGGTCTGTCGGTGGTCAACGCCCTGTCGGCCAGGCTGTCGGCGGAGATCTGGACGGACGGCCACCGCTGGACGCAGGACTACCGGGACGGCGCTCCCACCGCCCCACTGGTCCGCCGGGAGGCCACCTCCCGCACGGGCACCTCACTGACCTTCTGGGCGGACGGCTCCATCTTCGAGACCACCGACTACTCCTTCGAGACGCTGGCCAGGCGTTTCCAGGAGATGGCCTTCCTCAACCGTGGGCTCACGCTGACCCTCACCGACGAACGGGCCTCCGCGCGCGCCACGGCCGCGACCGACGAGGTCCACCCGGACCCGGCGGCGAAGACGGTCTCCTACCGCTACGACGGCGGCATCACCGACTTCGTCGCGTATCTCAACTCCCGCAAGGGCGAACCGGTCCATCCCTCGGTCGTCACCATCGCCGCCGACGACACGGAGCGGCTGCTGTCGGCCGAGATCGCGCTCCAGTGGAACGGCCAGTACACCGACAGCGTGTACTCGTACGCCAACGCGATCCACACCCACGAGGGCGGCACCCACGAGGAGGGCTTCCGTACGGCCCTGACCACCGTGGTCAACCGCTACGCGCGGGACAAGAAGCTGCTGCGGGAGAAGGACGCGAACCTCGCCGGCGAGGACATCCGTGAGGGGCTGACCGCGATCATCTCGGTCAAGCTCAGAGAACCGCAGTTCGAGGGCCAGACCAAGACCAAACTCGGCAACACGGAGGTGCGCACCTTCGTCCAGAAGGTCGTCCACGAGCATCTGACCGACTGGTTCGACCGCAACCCGAACGAGGCCGCGGACATCGTGCGCAAGGCCGTTCAGGCCGCCACGGCCCGGGTCGCGGCCCGTAAGGCGCGGGATCTGACCCGCCGTAAGGGCCTGCTGGAGACGGCGTCGCTGCCGGGCAAGCTGTCGGACTGTCAGTCGAACGACCCGGCGATGTCGGAGATCTTCATCGTCGAGGGAGACTCCGCCGGCGGCTCGGCCAAATCCGGCCGCAATCCGCAGTACCAGGCGATCCTCCCGATCCGGGGGAAGATCCTCAATGTCGAGAAGGCGCGGATCGACAGGATTTTGCAGAACCAGGAGATCCAGGCGCTCATCTCCGCGTTCGGCACGGGTATGCACGAGGACTTCGACATCGCCAAGCTCCGCTACCACAAGGTCATCTTGATGGCGGACGCCGACGTCGACGGCCAGCACATCAACACCCTGCTGCTGACCGTCCTGTTCCGCTTCATGCGGCCACTGATCGAGGAGGGGCACGTCTACCTCTCGCGCCCGCCGCTCTACAAGATCAAGTGGAGCCGGGACCACGTCGAGTACGCCTACTCCGACCGCGAACGCGACACGCTGCTGGAACTGGGCCGTCGGGACGGCCGCAGGGTCAGGGACGACTCCATCCAGCGCTTCAAGGGCCTCGGCGAGATGAACGCCGAGGAACTGCGCGTCACCACCATGGACCCCGACCACCGGGTGCTGGGGCGGGTCGCCCTCGACGACGCGGCCGTCGCCGACGACCTCTTCTCGGTTCTGATGGGTGAGGACGTGGAAGCCCGCCGCCACTTCATCCAGCGCAACGCCAAGGACGTCCGCTTCCTCGACATCTGA	MTSYDTRTATDTPGPQLPGQVGTASYDADAITVLDGLDAVRKRPGMYIGSTGERGLHHLVQELVDNSVDEALAGVADRIDVTVLADGGVRVVDNGRGIPVGMHPVEKRPAVEVVLTVLHAGGKFGGGGYTVSGGLHGVGLSVVNALSARLSAEIWTDGHRWTQDYRDGAPTAPLVRREATSRTGTSLTFWADGSIFETTDYSFETLARRFQEMAFLNRGLTLTLTDERASARATAATDEVHPDPAAKTVSYRYDGGITDFVAYLNSRKGEPVHPSVVTIAADDTERLLSAEIALQWNGQYTDSVYSYANAIHTHEGGTHEEGFRTALTTVVNRYARDKKLLREKDANLAGEDIREGLTAIISVKLREPQFEGQTKTKLGNTEVRTFVQKVVHEHLTDWFDRNPNEAADIVRKAVQAATARVAARKARDLTRRKGLLETASLPGKLSDCQSNDPAMSEIFIVEGDSAGGSAKSGRNPQYQAILPIRGKILNVEKARIDRILQNQEIQALISAFGTGMHEDFDIAKLRYHKVILMADADVDGQHINTLLLTVLFRFMRPLIEEGHVYLSRPPLYKIKWSRDHVEYAYSDRERDTLLELGRRDGRRVRDDSIQRFKGLGEMNAEELRVTTMDPDHRVLGRVALDDAAVADDLFSVLMGEDVEARRHFIQRNAKDVRFLDI	MMQEKKQTYDENQIQVLEGLEAVRKRPGMYIGSTSSRGLHHLVYEIVDNSIDEALAGYCDKINVIIHKDNSITVTDNGRGMPVGMHHKMKKPTVEVIMTILHAGGKFGGGGYKVSGGLHGVGASVVNALSEICEVEVKRESHIWRQVFKRGKVASGLDIIGDSEEHGTKIHFKPDAEIFDEIEYDYDTLAQRLRELAFLNKGIKIRLEDERDDKEEIFHYEGGIKSFVTYLNRNKQPIHKEPIYVEGKKDDYSVEIAIQYNDGYTENIFAFANNIDTVEGGTHLAGFKSALTRVFNDYAKKFGILKENDKNLSGEDIREGLTAVISVKLVDPQFEGQTKTKLGNSEVRGIVDSIMGESLNNFLQENPQVAKMILDKSLMASRAREAARKARELTRRKSILENTSLPGKLADCSSKDPSECEIYLVEGDSAGGSAKQGRNRKFQAILPLRGKIMNVEKQRLDKILGYEEIRAMITAFGAGIGKDFDVNKIRYNKIIIMTDADVDGAHIRTLLLTFFFRYMKELVEKCHVYIAQPPLYRVAKGKKEYYAYSDDELDVLLTEIGGKDSNVDIQRYKGLGEMDSEQLWDTTMNPETRTLIQVNVEDTMAADEIFTILMGDKVEPRRNFIQENAKKVVNLDI	106.28	gnl|BL_ORD_ID|4723|hsp_num:0	3268			6	1911	ciprofloxacin; levofloxacin; moxifloxacin; gemifloxacin
BGC0000834.1|Novobiocin_17 # 16048 # 16878 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGT;rbs_spacer=9bp;gc_cont=0.696	BGC0000834.1|Novobiocin_17 	16048	16878	+	Loose	2000	27.7202	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol	31.03	3003453	protein variant model	G350D	n/a	polyamine antibiotic	antibiotic target alteration	ethambutol resistant embA	ATGCTCGGGCGAGATCTGGTGGCGCTCCTGCGAGGGCTGAACGAACCGGTGGTCGCCATCACCCGGCACGATCTCGACATCACCGACCGCCTCTCGGTCCGGGCCGTTGTCGACAGGCACCGGCCGACGACCATCGTCAACTGCGCCGCCTGGACACGATTCGGCGAGGCGGAGGCCGGCGAATCGGCGGCCCTTCTCGTCAACGGAGGAGGGGCCCGGGAGCTGGCCGCGGTATGCCGTGATCGATCGATACGGCTGGTCCACCTCTCCACCGATTACGTCTTCGACGGCACGAGCCGCCGCCCCTACGCCGAAAGCGCGGTCACGAGCCCGATCAACGCGTACGGCCGGACGAAGCAGGCCGGCGAACAGGCGGTGCTCGACCTGCTGCCGGACGACGGCACGATCGTACGAACCGCCTGGCTGTACGGGCGGCACGGCATGAACTTCATCCGCAAGATGGTCCGGCTGGAGCAGCTGCGCGAGACCGTGGACGTGGTGGACGACCAGTGGGGCCAGCCGACCTGGACCGTGGATCTGGCACAGCAGATCGTGGCACTCGTCCGGCACGGTGCGTCCGGCGTGTTCCACGGAACGAGCGCGGGCGAGGCCACCTGGTACGACCTCGCCCGCATGACCTTCCGGCTGCTCGGCGCGGACCCCGGACGAGTGCGCCCGGTGCCCAGCGACCGGATCGCCGGCGGTGAACTGCGGCCCCGGTACACGGTGTTGGGGCATGACGCCTGGCGGGAGGCCGGGCTGACACCGATCCGGCACTGGACCACCGCTCTGACGCAGGCGTTCCCCCTGCTGAACGCCGATGAATCGTAG	MLGRDLVALLRGLNEPVVAITRHDLDITDRLSVRAVVDRHRPTTIVNCAAWTRFGEAEAGESAALLVNGGGARELAAVCRDRSIRLVHLSTDYVFDGTSRRPYAESAVTSPINAYGRTKQAGEQAVLDLLPDDGTIVRTAWLYGRHGMNFIRKMVRLEQLRETVDVVDDQWGQPTWTVDLAQQIVALVRHGASGVFHGTSAGEATWYDLARMTFRLLGADPGRVRPVPSDRIAGGELRPRYTVLGHDAWREAGLTPIRHWTTALTQAFPLLNADES	MPHDGNERSHRIARLAAVVSGIAGLLLCGIVPLLPVNQTTATIFWPQGSTADGNITQITAPLVSGAPRALDISIPCSAIATLPANGGLVLSTLPAGGVDTGKAGLFVRANQDTVVVAFRDSVAAVAARSTIAAGGCSALHIWADTGGAGADFMGIPGGAGTLPPEKKPQVGGIFTDLKVGAQPGLSARVDIDTRFITTPGALKKAVMLLGVLAVLVAMVGLAALDRLSRGRTLRDWLTRYRPRVRVGFASRLADAAVIATLLLWHVIGATSSDDGYLLTVARVAPKAGYVANYYRYFGTTEAPFDWYTSVLAQLAAVSTAGVWMRLPATLAGIACWLIVSRFVLRRLGPGPGGLASNRVAVFTAGAVFLSAWLPFNNGLRPEPLIALGVLVTWVLVERSIALGRLAPAAVAIIVATLTATLAPQGLIALAPLLTGARAIAQRIRRRRATDGLLAPLAVLAAALSLITVVVFRDQTLATVAESARIKYKVGPTIAWYQDFLRYYFLTVESNVEGSMSRRFAVLVLLFCLFGVLFVLLRRGRVAGLASGPAWRLIGTTAVGLLLLTFTPTKWAVQFGAFAGLAGVLGAVTAFTFARIGLHSRRNLTLYVTALLFVLAWATSGINGWFYVGNYGVPWYDIQPVIASHPVTSMFLTLSILTGLLAAWYHFRMDYAGHTEVKDNRRNRILASTPLLVVAVIMVAGEVGSMAKAAVFRYPLYTTAKANLTALSTGLSSCAMADDVLAEPDPNAGMLQPVPGQAFGPDGPLGGISPVGFKPEGVGEDLKSDPVVSKPGLVNSDASPNKPNAAITDSAGTAGGKGPVGINGSHAALPFGLDPARTPVMGSYGENNLAATATSAWYQLPPRSPDRPLVVVSAAGAIWSYKEDGDFIYGQSLKLQWGVTGPDGRIQPLGQVFPIDIGPQPAWRNLRFPLAWAPPEADVARIVAYDPNLSPEQWFAFTPPRVPVLESLQRLIGSATPVLMDIATAANFPCQRPFSEHLGIAELPQYRILPDHKQTAASSNLWQSSSTGGPFLFTQALLRTSTIATYLRGDWYRDWGSVEQYHRLVPADQAPDAVVEEGVITVPGWGRPGPIRALP	25.23	gnl|BL_ORD_ID|1961|hsp_num:0	1354			915	1080	ethambutol
